PT1169029E - Utilizacao de sibutramina ou seus derivados para o tratamento de disturbios do sono - Google Patents

Utilizacao de sibutramina ou seus derivados para o tratamento de disturbios do sono

Info

Publication number
PT1169029E
PT1169029E PT00918094T PT00918094T PT1169029E PT 1169029 E PT1169029 E PT 1169029E PT 00918094 T PT00918094 T PT 00918094T PT 00918094 T PT00918094 T PT 00918094T PT 1169029 E PT1169029 E PT 1169029E
Authority
PT
Portugal
Prior art keywords
sibutramine
derivatives
treatment
sleep disturbances
snoring
Prior art date
Application number
PT00918094T
Other languages
English (en)
Inventor
Sharon Crawford Cheetham
Heal David John
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Safer Anton
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of PT1169029E publication Critical patent/PT1169029E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Harvester Elements (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00918094T 1999-03-19 2000-03-17 Utilizacao de sibutramina ou seus derivados para o tratamento de disturbios do sono PT1169029E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12518599P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
PT1169029E true PT1169029E (pt) 2005-08-31

Family

ID=22418567

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00918094T PT1169029E (pt) 1999-03-19 2000-03-17 Utilizacao de sibutramina ou seus derivados para o tratamento de disturbios do sono

Country Status (26)

Country Link
US (1) US6365631B1 (pt)
EP (1) EP1169029B1 (pt)
JP (1) JP2003521469A (pt)
KR (1) KR100682291B1 (pt)
CN (1) CN1161114C (pt)
AT (1) ATE294573T1 (pt)
AU (1) AU773489B2 (pt)
BG (1) BG106001A (pt)
BR (1) BR0009080A (pt)
CA (1) CA2367022A1 (pt)
CZ (1) CZ298293B6 (pt)
DE (1) DE60019914T2 (pt)
DK (1) DK1169029T3 (pt)
ES (1) ES2244420T3 (pt)
HK (1) HK1044462B (pt)
HU (1) HUP0200501A3 (pt)
IL (2) IL145244A (pt)
MX (1) MXPA01009464A (pt)
NO (1) NO20014475L (pt)
NZ (1) NZ514014A (pt)
PL (1) PL359467A1 (pt)
PT (1) PT1169029E (pt)
SI (1) SI1169029T1 (pt)
SK (1) SK285308B6 (pt)
WO (1) WO2000056314A1 (pt)
ZA (1) ZA200107678B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6610887B2 (en) 2001-04-13 2003-08-26 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
BR0315084A (pt) * 2002-10-05 2005-08-16 Hanmi Pharm Ind Co Ltd Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
US20050228052A1 (en) * 2004-01-29 2005-10-13 Barberich Timothy J Methods of treating, preventing and managing a sleep disorder using (S)-didesmethylsibutramine
ES2337700T3 (es) * 2004-02-18 2010-04-28 Sepracor, Inc. Terapia combinada de agonista de dopamina con sedantes para mejorar la calidad del sueño.
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
EP2083867A1 (en) * 2006-11-22 2009-08-05 SK Chemicals, Co., Ltd. Inclusion complex of sibutramine and beta-cyclodextrin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
IL177626A0 (en) 2006-12-31
CZ298293B6 (cs) 2007-08-15
NZ514014A (en) 2004-02-27
CN1161114C (zh) 2004-08-11
ZA200107678B (en) 2003-06-18
EP1169029A1 (en) 2002-01-09
SK13382001A3 (sk) 2002-04-04
EP1169029B1 (en) 2005-05-04
IL145244A0 (en) 2002-06-30
PL359467A1 (en) 2004-08-23
CA2367022A1 (en) 2000-09-28
CZ20013280A3 (cs) 2002-07-17
HUP0200501A2 (en) 2002-08-28
AU773489B2 (en) 2004-05-27
NO20014475L (no) 2001-11-14
CN1356897A (zh) 2002-07-03
HUP0200501A3 (en) 2004-03-29
HK1044462A1 (en) 2002-10-25
EP1169029A4 (en) 2004-01-21
KR100682291B1 (ko) 2007-02-15
BG106001A (en) 2002-06-28
BR0009080A (pt) 2002-02-13
KR20010113847A (ko) 2001-12-28
AU3896800A (en) 2000-10-09
DE60019914T2 (de) 2006-05-04
DK1169029T3 (da) 2005-08-29
SI1169029T1 (sl) 2005-12-31
US6365631B1 (en) 2002-04-02
MXPA01009464A (es) 2004-03-19
IL145244A (en) 2006-12-10
SK285308B6 (sk) 2006-10-05
JP2003521469A (ja) 2003-07-15
NO20014475D0 (no) 2001-09-14
DE60019914D1 (de) 2005-06-09
WO2000056314A1 (en) 2000-09-28
HK1044462B (zh) 2006-03-03
ATE294573T1 (de) 2005-05-15
ES2244420T3 (es) 2005-12-16

Similar Documents

Publication Publication Date Title
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
TR200102646T2 (tr) Yeme bozukluklarının tedavi edilmesi.
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
DE60133389D1 (de) Gabapentinanaloga für schlafstörungen
NO991425D0 (no) Medisinsk behandling
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
WO2000056315A8 (en) Treatment of pain
NO982989L (no) Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering
TW349864B (en) Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
MXPA01009461A (es) Tratamiento de osteoartritis.
MXPA01009469A (es) Tratamiento para disminuir la adhesividad de las plaquetas.
SE0203778D0 (sv) A new oral immediated release dosage form
BG106000A (en) Treatment of hiatial hernia
MXPA01009462A (es) Tratamiento de calculos biliares.
NO20053612L (no) 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet